## Core Concept
The question pertains to the neurochemical basis of mood disorders, specifically mania. Mania is associated with an imbalance in certain neurotransmitter systems in the brain.

## Why the Correct Answer is Right
The correct answer, **Dopamine**, is implicated in the pathophysiology of mania. Research suggests that increased dopaminergic activity may contribute to the development of manic symptoms. Dopamine is involved in the regulation of mood, reward, and motivation, and its dysregulation can lead to mood instability.

## Why Each Wrong Option is Incorrect
* **Option A: Serotonin** - While serotonin is indeed involved in mood regulation and is a target for many antidepressants and mood stabilizers, decreased serotonergic activity, rather than increased, is often associated with depression and mood instability. However, its direct link to mania as a primary increased neurotransmitter is less clear compared to dopamine.
* **Option B: GABA** - GABA (gamma-aminobutyric acid) is an inhibitory neurotransmitter, and alterations in GABAergic function have been implicated in various psychiatric conditions. However, it is not specifically known for being increased in mania.
* **Option C: Acetylcholine** - Acetylcholine plays a role in various cognitive functions and has been implicated in mood disorders, but it is not primarily associated with the pathophysiology of mania.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that lithium, a drug used to treat mania, affects multiple neurotransmitter systems, including dopamine, serotonin, and inositol signaling pathways. This highlights the complex neurochemical underpinnings of mood disorders.

## Correct Answer Line
**Correct Answer: D. Dopamine**